Cytogen Inc (217330.KQ) stock: key figures, P/E, revenue and dividend
Energy · Coal & Consumable Fuels · South Korea · ISIN KR7217330000
Cytogen Inc financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 10.91 bn KRW | 26.05 bn KRW |
| Gross profit | 2.83 bn KRW | 5.61 bn KRW |
| Operating income | -14.03 bn KRW | -7.48 bn KRW |
| EBIT | -15.84 bn KRW | -10.62 bn KRW |
| Net income | -17.12 bn KRW | -12.34 bn KRW |
| Diluted EPS – continuing operations | -741.97 KRW | -533.70 KRW |
Full history since 2014, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Cytogen Inc
Cytogen, Inc., a biotechnology company, engages in blood cancer cell-based Liquid Biopsy application business in South Korea. The company offers cell isolators that enrich CTCs from human blood and/or body fluid using high density microporous chips; IF stainers, automated immunofluorescent staining system; and cell image analyzers, which help captures immunofluorescent images of cells stained with anti-EpCAM, -CD45, and CK antibodies. The company sells its products under the Smart Biopsy brand name. Cytogen, Inc. was founded in 2010 and is headquartered in Seoul, South Korea.
More stocks
- HYPERION DEFI, INC. (HYPD)
- Carbon-Based Technology Inc. (7719.TWO)
- Protia Inc. (303360.KQ)
- VirnetX Holding Corp (VHC)
- Precipio, Inc. (PRPO)
- XTI Aerospace, Inc. (XTIA)
- Momentus Inc. (MNTS)
- Eltek Ltd (ELTK)
- Galaxy Gaming, Inc. (GLXZ)
- Heritage Global Inc. (HGBL)
- Texxon Holding Ltd. (NPT)
- HOOPS SCOUTING USA (HSCT)
Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.